Loading company
Co-Diagnostics, Inc.
CODX · Nasdaq · ·
$1.09+0.5%Sep 29 close
- 1M
- -9.9%
- 6M
- -35.9%
- 1Y
- -89.4%
- 5Y
- -99.6%
CODX · Nasdaq · ·
$1.09+0.5%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $166.1K | $162.9K | +1.98% |
| Profit | -$6.3M | -$7.7M | +18.71% |
| Profit per share | -$1.46 | -$7.05 | +79.29% |
| Free Cash Flow | -$7.2M | -$8.7M | +17.47% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Co-Diagnostics, Inc. has no earnings call transcript available.
“Our second quarter marked a period of meaningful operational progress for Co-Diagnostics, as years of investment across our platform are illustrated by these tangible milestones,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
The quote and the company description come from Co-Diagnostics, Inc.’s Item 2.02 8-K filed August 13, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.